Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid with hyaluronic acid plus physiotherapy for hip pathologies
NCT06653985Recruiting
- Sponsor
- ArthroBiologix Inc.
- Start
- May 2024
- Primary completion
- Oct 2026
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of triamcinolone and hyaluronic acid in osteoarthritis (OA), femoroacetabular impingement syndrome (FAI) and Labral tear (2 arms), sponsored by ArthroBiologix Inc. Primary endpoint: Numeric Pain Rating Scale at 6 months. Started May 2024; status: recruiting.
02
Drugs
triamcinolonehyaluronic acid
03
Conditions
osteoarthritis (OA)femoroacetabular impingement syndrome (FAI)Labral tear
Beyond the preview
Go deeper on NCT06653985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06653985.